Boehringer Ingelheim recently announced that OFEV (nintedanib) has been recommended by the National Institute for Health and Care Excellence (NICE) as a treatment for idiopathic pulmonary fibrosis (IPF) within the National Health Service (NHS) in England and in Wales. Nintedanib, an oral small molecule tyrosine kinase inhibitor, is recommended for…
“Marilyn first noticed something was wrong when she kept getting colds and breathing became more difficult. In this video she shares her struggle to get diagnosed with IPF, a condition that causes scarring of the lungs and has no cure.” Learn more about IPF: https://bit.ly/1QiRmr3…
https://www.youtube.com/watch?v=YrdhNG1hbv0 “Lung function of an IPF patient gradually and irreversibly declines.” Learn more about idiopathic pulmonary fibrosis: https://bit.ly/1QiRmr3…
Clinical trials are well-designed studies used to collect information about new treatments for diseases and disorders. Most of the time, this means medications, but clinical trials can also test other things, such as stem cell therapies, surgical techniques, tests for diagnosis, medical devices, as well as…
“This simple video presents a basic understanding of idiopathic pulmonary fibrosis (IPF). This fatal condition does not have a known cause and research investigating its pathology is ongoing.” Learn more about Idiopathic Pulmonary Fibrosis: https://bit.ly/1QiRmr3…
Researchers discovered that mechanotherapy on damaged muscle tissue reduces both fibrotic tissue accumulation and inflammation while helping to increase tissue regeneration, according to a new study titled “Biologic-free mechanically induced muscle regeneration,” published in the journal Proceedings of the National Academy of Sciences (PNAS). Although focusing on the repair…
https://www.youtube.com/watch?v=98vpzgy94kk Learn more about IPF: https://bit.ly/1QiRmr3…
Watch the president and CEO of the Pulmonary Fibrosis Foundation, Dr. Daniel M. Rose, talk about the disease. Learn more about IPF: https://bit.ly/1QiRmr3…
Spherix Global Insights, GmbH, a business intelligence and market research company based in Switzerland, recently reported a study revealing that idiopathic pulmonary fibrosis (IPF) remains a challenge in terms of treatment, especially since the majority of patients are diagnosed at already advanced disease stages. The Spherix…
UT Health Northeast, a medical center that is part of the University of Texas system, recently announced in a press release that four of its scientists have received a total of $2.1 million in competitive research grants. The researchers are Dr. Vijay Rao, Dr. Krishna Vankayalapati, Dr. Hong-Long Ji,…
Get regular updates to your inbox.
